Walker & Dunlop, Inc. (WD): what the price assumes

In the published model solve dated 2026-Q2, anchored at $51.45, Walker & Dunlop, Inc. (WD) is priced for +9.5% earnings growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/WD

Headline

FieldValue
TickerWD
CompanyWalker & Dunlop, Inc.
Current price$51.46/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfee-financial
Implied earnings growth9.5%
Price-to-earnings16.7x
Earnings yield6.0%

Solve inputs: computed at a 11.8% cost of equity with 4% terminal growth over a 5-year stage, on a 5-year median GAAP earnings base; each 1pp of cost of equity moves the implied earnings growth ~3.3pp.

Reconcile: at the x-ray's 9.3% required return this reads ~0.2%/yr; the models below use their own rates.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.00σ
cohort percentile (of 51 peers)20
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset3.02x4expensive
Earnings2.36x1expensive
Relative0
Growth0.73x2justifies

Families that justify the price: Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 3.9%); the inversion above states its own rate.

Per-Model Detail (n=7)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthnoNegative/zero FCF — equity value floored at $0
DCF Exit MultipleGrowthnoNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelativenoP/E 18x (static sector reference · 2026-04), scenarios: 14.8x / 18.0x / 21.2x (bear / base = reference held flat / bull), EV/EBITDA 12x
Simple DDMGrowth$54.840.94xyesDPS $2.75, g=4.0% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$97.530.53xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$21.842.36xyesBV/sh $50.11, ROE (TTM) 4.0%, ke 9.3%
Two-Stage Excess ReturnAsset$13.973.68xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowthnoRev $1.3B, growth 15% (input: historical growth; tapered), Terminal P/S: 1.1x / 1.4x / 1.6x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelativenoEPS $2.02, growth 1% (input: historical EPS growth), PEG=25.03 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAsset$11.184.60xyesBV $50.11 + 5yr PV of (ROE (TTM) 4.0% − Kₑ 9.3%) × BV; BV grows 2.6%/yr
Graham NumberAsset$47.721.08xyes√(22.5 × EPS $2.02 × BVPS $50.11) — Graham's conservative floor
EV/EBITDA RelativeRelativenoEBITDA $0.24B × sector EV/EBITDA 12.0x
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsnoEPS $2.02 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativenoRevenue $1.30B × sector P/S 2.5x
PEG Fair ValueRelativenoEPS $2.02 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$21.842.36xyesEPS $2.02 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Share count CAGR (dilution)0.6%

Corporate solvency inputs do not resolve from the filings for this fee business (operating income or debt concepts are untagged), so net-debt and coverage lenses are suppressed rather than rendered from artifacts. Share-count CAGR is kept.

Bullet Takeaways

Bull Case

The clearest signal in Walker & Dunlop's first quarter is the trajectory, and it points up sharply. Total transaction volume nearly doubled, rising 94% year over year to $13.7 billion, and that flowed straight into the income statement: revenue rose to $301.3 million and diluted EPS came in at $1.02, far above the roughly $0.33 the Street had penciled in. This is what an originator looks like coming off the bottom of a rate-frozen commercial real estate market. When transactions seize up, Walker & Dunlop's fee revenue dries; when they thaw, it surges. The first quarter says the thaw is underway, and the company is capturing it.

The business has two engines, and the bull case rests on both turning together. The first is origination: the company originates loans for Fannie Mae, Freddie Mac and HUD, earning fees from borrowers at closing. That engine is cyclical, and it is the one that just doubled. The second is servicing, and it is the steady one. The company keeps servicing the loans it originates, earning recurring fees for processing payments, managing escrow, and performing asset-management functions, and the servicing portfolio grew 8% to $146.4 billion even through the down cycle. That portfolio is the annuity that pays the bills while origination waits for rates to cooperate, and crucially, on the agency loans the company holds strong prepayment protections that reduce the risk of the servicing stream evaporating when borrowers refinance.

The model also enjoys a structural tailwind from how borrowers are behaving now. Higher rates have pushed clients toward shorter-term, five-year loans, which made up 54% of 2025 agency lending, as borrowers buy optionality to refinance or sell as conditions change. Shorter terms mean loans cycle back through Walker & Dunlop's origination machine sooner, generating fresh fees on each turn. A recovering transaction market combined with a faster refinancing clock is exactly the setup that turns a fee business into a compounding one, and it is why the valuation methods that credit growth reach the price while the static ones do not.

Bear Case

Look first at how the company makes money for shareholders versus how it reports its results, because that is where the bear case starts. Walker & Dunlop leans heavily on adjusted figures, and the gap between a clean GAAP read and the adjusted-core framing the company emphasizes is the kind of thing a careful holder watches. The first quarter's headline strength rests substantially on a transaction rebound that the company does not control, and the durability of the earnings depends on how much of the reported result is recurring servicing income versus one-time origination gains tied to a volume spike. A doubling of transaction volume off a depressed base is a recovery, not a run rate.

The core fragility is that origination is a rate-driven, cyclical fee business wearing the clothing of a steady financial. The 94% volume jump is impressive precisely because the prior-year base was so weak, and the same sensitivity that produced the surge produces the droughts. If long rates back up again, commercial real estate transactions slow, origination fees fall, and the operating leverage that just worked in the company's favor reverses. The shift toward five-year loans cuts two ways: it brings borrowers back sooner, but it also means a larger share of the book is short-dated and rate-exposed, and on loans serviced outside the agency channel the company concedes it typically lacks the prepayment protections that shield its Fannie, Freddie and HUD servicing, so a refinancing wave can erode the servicing annuity faster than the headline portfolio growth suggests.

The balance sheet leaves modest room for a downturn. Net debt of roughly $633 million sits at about five times trailing operating income, and operating earnings cover interest only about twice over. For a business whose revenue can swing by tens of percent with the rate cycle, interest coverage of two times is thin; a year like the one the company is recovering from would pressure that coverage just as fee income falls. The valuation already prices the recovery: the methods grounded in current earnings power and in peer multiples land below the price, and only the methods that assume the rebound compounds reach it. The bear case is not that the quarter was bad. It is that a cyclical fee originator at the start of an up-cycle is being priced as if the up-cycle is the permanent state.

Valuation

Walker & Dunlop is a fee-based financial, so the right lens is the durability of its earnings rather than an operating margin or a book-value multiple, and the price is making a clear bet: that the transaction recovery now underway is the start of durable growth, not a one-quarter snap-back. The methods sort accordingly. The asset-value and earnings-power lenses, which value the company on its balance sheet and its current profit stream, land well below the price; peer multiples land below it too. Only the methods that project growth forward reach $51.84 (June 28, 2026). That is the familiar signature of a price paying for compounding the static frames cannot capture, and for a cyclical fee business it carries an extra warning: the forward methods are extrapolating from a quarter in which volume nearly doubled off a depressed base.

Interestingly, the dividend-based methods tell a more generous story here than the multiple-based ones, landing at or above the price, which reflects the recurring servicing income the company collects regardless of the transaction cycle. That is the genuine value anchor in the business. The servicing portfolio of $146.4 billion throws off fees for processing payments and managing escrow that do not depend on new originations, and the agency loans carry prepayment protections that make those fees stickier than they would otherwise be. The split between the demanding multiple methods and the supportive dividend methods is, in plain terms, the split between the volatile origination fees and the steady servicing fees.

Solvency is the constraint to weigh against the cyclicality. Net debt of roughly $633 million sits at about five times trailing operating income, with interest covered close to two times by operating earnings. That coverage is adequate in a recovering market but leaves little cushion if origination volume turns down again, because the same operating leverage that amplified the first quarter's earnings would amplify a decline. The decisive judgment for the value is not a single method's number; it is how much of the recent surge in transaction volume is a durable rate-driven recovery versus a rebound from an unusually weak prior year.

Catalysts

The April 2026 first-quarter report was the catalyst, and it was a large upside surprise driven by a transaction rebound. Total transaction volume rose 94% year over year to $13.7 billion, revenue reached $301.3 million, and diluted EPS of $1.02 dwarfed the roughly $0.33 expectation. Adjusted EBITDA rose 14% to $73.8 million, and the servicing portfolio grew 8% to $146.4 billion. The market read it as confirmation that the commercial real estate financing market is thawing after a rate-frozen stretch.

The forward catalysts all run through interest rates and the transaction cycle they govern. The company highlighted a shift toward five-year loan terms, which reached 54% of 2025 agency lending as borrowers sought flexibility in an uncertain rate environment; that behavior brings loans back through the origination engine sooner, so the pace of refinancing activity is a key thing to watch. The single most important external variable is the direction of long-term rates: a continued thaw extends the recovery in origination fees, while a renewed back-up in rates would slow transactions and test the cyclical earnings. The next quarterly report is the event that shows whether the first quarter's volume surge is building into a trend or fading back toward the depressed prior-year run rate.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

FY2025 10-K, accession 0001104659-26-020249 · Q1 2026 earnings release, April 2026 · Q1 2026 earnings call, April 2026

View the full interactive WD report on boothcheck